Glutathione S-Transferases and iododeoxyuridine labelling index during chemotherapy of gastric cancer

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1705-1710

  Schipper, D L ^b   Wagenmans, M J M ^b   Peters, W H M ^a   Wils, J A J M ^b   Wagener, D J T ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Chemotherapy resistance; Gastric cancer; Glutathione; Glutathione S transferase; Iododeoxyuridine labeling

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IDOXURIDINE; METHOTREXATE; PYRIMIDINE ANTAGONIST;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROSCOPY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; ENDOSCOPY; FEMALE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOPROTEINS; HUMANS; IDOXURIDINE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; STOMACH NEOPLASMS;

EID: 0033854771     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Dupont JB, Lee JR and Burton GR, et al: Adenocarcinoma of the stomach: review of 1497 cases. Cancer 41: 941 - 953, 1987.
2. Gottesman MM: How cancer cells evade chemotherapy. Cancer Res 53: 747 - 754, 1993.
3. Ford JM and Hait WN: Pharmacologic circumvention of multidrug resistance. Cytotechnology 12: 171 - 212, 1993.
4. Sikic BI: Modulation of multidrug resistance: at the treshold. J Clin Oncol 11: 1629 - 1635, 1993.
5. Nooter K and Sonneveld P: Clinical relevance of P-glycoprotein expression in haematological malignancies. Leuk Res 18: 233 - 243, 1994.
6. Mirski SEL, Gerlach JH and Cole SPC: Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.Cancer Res 47: 2594 -2598, 1987.
7. Zijlstra JG, De Vries EGE and Mulder NH: Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780 - 1784, 1987.
8. Baas F, Jongsma A and Broxterman HJ et al: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 50: 5392 -5398, 1990.
9. Cole SPC, Bhardwaj G and Gerlach JH et al: Overexpression of a transporter gene in a multi-drug resistant human lung cancer cell line. Science 258: 1650 - 1654, 1992.
10. Zaman GJR, Versantvoort CHM and Smit JJM et al: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747 - 1750, 1993.
11. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG and Cole SPC: Localization of a novel multidrug resistance-associated gene in the HT 1080/DR4 and H69AR human tumor cell lines. Cancer Res 53: 3221 - 3225, 1993.
12. Krishnamachary N and Center MS: The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658 - 3661, 1993.
13. Barrand MA, Heppell-Parton AC, Wright KA, Rabbitts PH and Twentyman PR: A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 86: 110 - 117, 1994.
14. Versantvoort CHM, Broxterman HJ, Bagrij T, Scheper RJ and Twentyman PR: Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72: 82 - 89, 1995.
15. Mueller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, De Vries EGE and Jansen PLM: Overexpression of the gene encoding the multidrug resistance associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033 - 13037, 1994.
16. Kavallaris M: The role of multidrug resistance associated protein (MRP) expression in multidrug resistance. Anti-Cancer Drugs 8: 17 -25, 1997.
17. Peters WHM, Kock L, Nagengast FM and Kremers PG: Biotransformation enzymes in human intestine: critical low levels in the colon? Gut 32: 408 - 412, 1991.
18. Mannervik B and Danielsson UH: Glutathione S-transferases. Structure and catalytic activity. CRC Crit Rev Biochem 23: 283 - 337, 1988.
19. Townsend AJ, Cowan KH. Glutathione S-transferases and antineoplastic drug resistance. Cancer Bull 41: 31 - 37, 1989.
20. Black SM and Wolf CR: The role of glutathione-dependent enzymes in drug resistance. Pharmac Ther 51: 139 - 154, 1991.
21. Tsuchida S and Sato K: Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27: 337 - 384, 1992.
22. Moscow JA and Dixon KH: Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology 12: 155 - 170, 1993.
23. Tew KD: Glutathione-associated enzymes in anti-cancer drug resistance. Cancer Res 54: 4313 - 4320, 1994.
24. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445 - 600, 1995.
25. Mannervik B: The isoenzymes of glutathione S-transferase. Adv Enzymol 57: 357-417, 1985.
26. Meyer JD, Coles B, Pemhle SE, Gilmore KS, Fraser GM and Ketterer B: Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274: 409 - 414, 1991.
27. Peters WHM, Wormskamp NGM and Thies E: Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis 11: 1593 - 1596, 1990.
28. Schipper DL, Wagenmans MJM, Van Haelst U, Peters WHM, Wobbes T, Verhofstad AAJ, Lange WPH and Wagener DJT: Immunohistochemical determination of glutathione S-transferases in gastric carcinomas and in adjacent normal gastric epithelium. Anticancer Res 16: 565 - 572, 1996.
29. American Joint Committee on Cancer, 1991. Handbook for staging of cancer. Beahrs O.H, Henson D.E., Hutter R.V.P and Kennedy B.J, (eds.). Philadelphia: J.P. Lippincott Company, pp. 81 - 87.
30. Peters WHM, Boon CEW, Roelofs HMJ, Wobbes T, Nagengast FM and Kremers PG: Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology 103: 448 - 455, 1992.
31. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
32. Habig WH, Pabst MJ and Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
33. Peters WHM, Kock L, Nagengast FM and Roelofs HMJ: Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol 39: 591 - 597, 1990.
34. Van Ommen B, Bogaards JJP, Peters WHM, Blauwboer B and Van Bladeren PJ: Quantification of human hepatic glutathione S-transferases. Biochem J 269: 609 - 613, 1990.
35. Peters WHM, Nagengast FM and Wobbes T. Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis 10: 2371 - 2374, 1989.
36. Kerstens HMJ, Poddighe PJ and Hanselaar AGJM: A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43: 347 - 352, 1995.
37. Koberda J and Hellman A: Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias. Med Oncol Tumor Pharmacother 8: 35 - 38, 1991.
38. Tidefelt U, Elmhorn-Rosenborg A, Paul C, Hao X-Y, Mannervik B and Eriksson LC: Expression of glutathione S-transferase π as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 52: 3281 - 3285, 1992.
39. Joncourt F, Oberli-Schrammli AE, Stadler M, Buser K, Franscini L, Fey MF and Cerny T: Patterns of drug resistance parameters in adult leukemia. Leuk Lymphoma 17: 101 - 109, 1995.
40. Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K and Hara N: Immunohistochemical expression of glutathione S-transferase Pi can predict chemotherapy response in patients with non small cell lung carcinoma. Cancer 78: 416-421, 1996.
41. Hamada S-I, Kamada M, Furumoto H, Hirao T and Aono T: Expression of glutathione S-transferase-Pi in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol Oncol 52: 313-319, 1994.
42. Green JA, Robertson LJ and Clark AH: Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 68: 235 - 239, 1993.
43. Hirazono K, Shinozuka T, Kuroshima Y, Itoh H and Kawai K: Immunohistochemical expression of glutathione S-transferase pi (GST-pi) and chemotherapy response in malignant ovarian tumors. J Obstet Gynaecol 21: 305 - 312, 1995.
44. Van Der Zee AGJ, Van Ommen B, Meijer C, Hollema H, Van Bladeren PJ and De Vries EGE: Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br J Cancer 66; 930 - 936, 1992.
45. Murphy D, Mcgrown AT, Hall A, Cattan A, Crowther D and Fox BW: Glutathione S-transferase activity and isoenzymc distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy. Br J Cancer 66: 937 - 942, 1992.
46. Van Der Zee AGJ, Hollema H, Suurmeijer AJH, Krans M, Sluiter WJ, Willemse PHB, Aalders JG and De Vries EGE: Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncol 13: 70 - 78, 1995.
47. Ghazal-Aswad S, Hogarth L, Hall AG, George M, Sinha DP, Lind M, Calvert AH, Sunter JP and Newell DR: The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients. Br J Cancer 74: 468 - 473, 1996.
48. Peters WHM, Roelofs HMJ, Van Putten WLJ, Jansen JBMJ, Klijn JGM and Foekens JA: Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 68: 86 - 92, 1993.
49. Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL and Horne CHW: Response to mitoxantrone in advanced breast cancer: Correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer 65: 271 - 274, 1992.
50. Toffoli G, Frustasi S, Tumiotto L, Talamini R, Gherlinzoni F, Picci P and Boiocchi M: Expression of MDR1 and GST-π in human soft tissue sarcomas: Relation to drug resistance and biological agressiveness. Ann Oncol 3: 63 - 69, 1992.
51. Nooter K and Sonneveld P: Multidrug resistance (MDR) genes in haematological malignancies. Cytotechnology 12: 213 - 230, 1993.
52. Chuman Y, Sumizawa T and Takebayashi Y et al: Expression of the multidrug-resistance associated protein (MRP) gene in human colorectal, gastric and non-small cell lung carcinomas. Int J Cancer 66: 274 - 279, 1996.
53. Endo K and Maehara Y et al: Multidrug resistance-associated protein expression in clinical gastric carcinoma. Cancer (Suppl) 77: 1681 -1687, 1996.